Table 4.
Mulvariate analyses of Hazard Ratios with Relapse-free Survival and Overall Survival in breast cancer patients (n=81).
Variables | Relapse-free Survival
|
Overall survival
|
||||
---|---|---|---|---|---|---|
HR | 95% CI | p | HR | 95% CI | p | |
γδ T (>9) | 34.68 | 4.79 to 250.88 | 0.0004 | 3.34 | 1.21 to 9.25 | 0.020 |
FoxP3 (>12) | 3.08 | 0.49 to 19.17 | 0.228 | 3.05 | 0.95 to 9.77 | 0.061 |
CD4 (>16) | 2.31 | 0.66 to 8.07 | 0.189 | 1.20 | 0.47 to 3.09 | 0.702 |
CD8 (>13) | 0.04 | 0.01 to 0.35 | 0.004 | 0.47 | 0.18 to 1.27 | 0.137 |
Stage (III vs I + II) | 5.24 | 1.25 to 22.02 | 0.023 | 2.17 | 0.83 to 5.67 | 0.114 |
Nodal (Pos) | 2.36 | 0.32 to 17.59 | 0.404 | 1.99 | 0.54 to 7.31 | 0.301 |
Note: Results obtained using the Cox proportional hazard regression model.
Abbreviations: HR, hazard ratio; FoxP3, forkhead box protein P3.